ArticleDiabetic medicine : a journal of the British Diabetic Association2018

Efficacy and safety of alirocumab in people with prediabetes vs those with normoglycaemia at baseline: a pooled analysis of 10 phase III ODYSSEY clinical trials.

L A Leiter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.